Header Logo

Connection

Mandisa Singata-Madliki to South Africa

This is a "connection" page, showing publications Mandisa Singata-Madliki has written about South Africa.
Connection Strength

0,518
  1. Implementing E-MOTIVE for detection and treatment of postpartum haemorrhage in South Africa. S Afr Med J. 2023 Dec 04; 113(12):24.
    View in: PubMed
    Score: 0,092
  2. Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomized trial. Int J Gynaecol Obstet. 2021 Aug; 154(2):256-262.
    View in: PubMed
    Score: 0,076
  3. Randomized feasibility study of suction-tube uterine tamponade for postpartum hemorrhage. Int J Gynaecol Obstet. 2019 Sep; 146(3):339-343.
    View in: PubMed
    Score: 0,068
  4. Psychological, behavioural and physiological effects of three long-acting reversible contraception (LARC) methods: protocol for an ancillary study of the ECHO randomised trial. BMJ Open. 2017 Nov 12; 7(11):e019205.
    View in: PubMed
    Score: 0,061
  5. Factors influencing postpartum haemorrhage detection and management and the implementation of a new postpartum haemorrhage care bundle (E-MOTIVE) in Kenya, Nigeria, and South Africa. Implement Sci. 2023 01 11; 18(1):1.
    View in: PubMed
    Score: 0,022
  6. Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial. J Acquir Immune Defic Syndr. 2022 09 01; 91(1):26-30.
    View in: PubMed
    Score: 0,021
  7. Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania. Int J Gynaecol Obstet. 2022 Jun; 158 Suppl 1:46-55.
    View in: PubMed
    Score: 0,021
  8. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
    View in: PubMed
    Score: 0,021
  9. Cumulative incidence of SARS-CoV-2 and associated risk factors among healthcare workers: a cross-sectional study in the Eastern Cape, South Africa. BMJ Open. 2022 03 18; 12(3):e058761.
    View in: PubMed
    Score: 0,020
  10. Growth, clinical and neurodevelopmental outcomes at school age are similar for children who received 1-year lamivudine or lopinavir/ritonavir HIV prophylaxis in early life. Sci Rep. 2021 02 04; 11(1):3173.
    View in: PubMed
    Score: 0,019
  11. Eastern Cape Healthcare Workers Acquisition of SARS-CoV-2 (ECHAS): Cross-Sectional (Nested Cohort) Study Protocol. Int J Environ Res Public Health. 2021 01 05; 18(1).
    View in: PubMed
    Score: 0,019
  12. Lopinavir-Ritonavir Impairs Adrenal Function in Infants. Clin Infect Dis. 2020 08 14; 71(4):1030-1039.
    View in: PubMed
    Score: 0,018
  13. Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2019 01 26; 393(10169):330-339.
    View in: PubMed
    Score: 0,016
  14. HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study. BMJ Open. 2018 04 05; 8(4):e019239.
    View in: PubMed
    Score: 0,016
  15. Participant recruitment and retention in longitudinal preconception randomized trials: lessons learnt from the Calcium And Pre-eclampsia (CAP) trial. Trials. 2017 Oct 26; 18(1):500.
    View in: PubMed
    Score: 0,015
  16. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
    View in: PubMed
    Score: 0,014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.